Cite
HARVARD Citation
Toma, M. et al. (n.d.). PARK2 and PACRG are commonly downregulated in clear‐cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcome. Genes, chromosomes & cancer. 52 (3), pp. 265-273. [Online].